Market Overview

Novus Therapeutics, Inc. (NVUS)

0.95 -0.03 (-2.71%)

Earnings

QuarterPriorEstimateActualSurprise
Q1 2021
Pre-Market
EPS:
REV:
-0.47
0



Q4 2020
Pre-Market
EPS:
REV:
-0.32
0



Q3 2020
Pre-Market
EPS:
REV:
-0.22
0



Q2 2020
Pre-Market
EPS:
REV:
-0.35
0

-0.15
0

Q1 2020
Pre-Market
EPS:
REV:
-0.52
0

-0.47
0

Q4 2019
Pre-Market
EPS:
REV:
-0.49

-0.32
0

Q3 2019
Pre-Market
EPS:
REV:
-0.37

-0.22
0

Q2 2019
Pre-Market
EPS:
REV:
-0.34
0
-0.42
-0.35
0
16.67%
Q1 2019
After-Hours
EPS:
REV:
-0.36
0
-0.48
-0.52
0
-8.33%
Q4 2018
Pre-Market
EPS:
REV:
-0.30
-0.40
-0.49
22.5%

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!